New Gene Therapy for Skin Wounds Improved Vision in Young Boy
(MedPage Today) -- Ophthalmic administration of beremagene geperpavec (B-VEC; Vyjuvek) improved visual acuity in a young patient with cicatrizing conjunctivitis due to dystrophic epidermolysis bullosa, researchers reported.
With treatment with...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news
More News: Conjunctivitis | Dermatology | Epidermolysis Bullosa | Gene Therapy | Genetics | Opthalmology | Skin